US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viridian Therapeutics, Inc.

13.12

+0.73005.89%

Post-market: 13.04-0.0800-0.61%17:14 EDT

Volume:942.93K

Turnover:12.35M

Market Cap:1.07B

PE:-3.94

High:13.38

Open:12.81

Low:12.75

Close:12.39

Loading ...

Overview Company News Filings

Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pharming Group (PHAR)

Viridian Therapeutics Shares up 19.8% After Co's Eye Disorder Drug Meets Late-Stage Study Goal

THOMSON REUTERS

Viridian Therapeutics Meets Endpoints in Late-Stage Veligrotug Trial for Thyroid Eye Disease

MT Newswires Live

BUZZ-Viridian jumps as thyroid eye disease drug meets late-stage study goal

Viridian Therapeutics announces THRIVE-2 trial met primary, secondary endpoints

Viridian Therapeutics Shares up 14.8% Premarket After Co's Eye Disorder Drug Meets Late-Stage Study Goal

THOMSON REUTERS

Viridian Therapeutics' eye disorder drug meets late-stage study goal

Viridian Therapeutics Inc: Veligrotug Met All Primary and Secondary Endpoints With High Statistical Significance in Thrive-2

THOMSON REUTERS

Viridian Therapeutics Inc - Veligrotug Well-Tolerated With 94% Completion Rate in Thrive-2 Trial

THOMSON REUTERS

Viridian Therapeutics Announces Positive Topline Results From Veligrotug Phase 3 Thrive-2 Clinical Trial in Patients With Chronic Thyroid Eye Disease

THOMSON REUTERS

Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease

Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024

Viridian Therapeutics Price Target Maintained With a $44.00/Share by RBC Capital

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

TD Cowen Initiates Viridian Therapeutics at Buy

MT Newswires Live

Viridian Therapeutics Price Target Maintained With a $38.00/Share by Needham

Viridian Therapeutics (VRDN) Has Captured Investors’ Attention with Recent Breakthroughs

Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Viridian Therapeutics Inc : H.c. Wainwright Raises Target Price to $34 From $27

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VRDN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRDN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRDN\",,,,,undefined,":{"symbol":"VRDN","market":"US","secType":"STK","nameCN":"Viridian Therapeutics, Inc.","latestPrice":13.12,"timestamp":1747080000000,"preClose":12.39,"halted":0,"volume":942925,"hourTrading":{"tag":"盘后","latestPrice":13.04,"preClose":13.12,"latestTime":"17:14 EDT","volume":31333,"amount":411065.14,"timestamp":1747084441831},"delay":0,"floatShares":72733653,"shares":81592026,"eps":-3.332524,"marketStatus":"Not Yet Opened","change":0.73,"latestTime":"05-12 16:00:00 EDT","open":12.81,"high":13.38,"low":12.75,"amount":12349094.582349999,"amplitude":0.050847,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332524,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747123200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":12.39,"preHourTrading":{"tag":"盘前","latestPrice":12.86,"preClose":12.39,"latestTime":"09:28 EDT","volume":2003,"amount":25432.279282,"timestamp":1747056485012},"postHourTrading":{"tag":"盘后","latestPrice":13.04,"preClose":13.12,"latestTime":"17:14 EDT","volume":31333,"amount":411065.14,"timestamp":1747084441831},"volumeRatio":1.0444271559628497,"impliedVol":1.318,"impliedVolPercentile":0.8755},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRDN\",,,,,undefined,":{"symbol":"VRDN","floatShares":72733653,"roa":"-32.62%","roe":"-51.95%","lyrEps":-3.072216,"volumeRatio":1.0444271559628497,"shares":81592026,"dividePrice":0,"high":13.38,"amplitude":0.050847,"preClose":12.39,"low":12.75,"week52Low":9.9,"pbRate":"2.58","psRate":"3544.66","week52High":27.2,"institutionHeld":0,"latestPrice":13.12,"eps":-3.332524,"divideRate":0,"volume":942925,"delay":0,"ttmEps":-3.332524,"open":12.81,"prevYearClose":19.17,"prevWeekClose":12.39,"prevMonthClose":13.55,"prevQuarterClose":13.48,"fiveDayClose":13.12,"twentyDayClose":12.02,"sixtyDayClose":17.02},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRDN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491618014","title":"Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pharming Group (PHAR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2491618014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491618014?lang=en_us&edition=fundamental","pubTime":"2024-12-16 23:30","pubTimestamp":1734363011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viridian Therapeutics (VRDN – Research Report) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-viridian-therapeutics-vrdn-pharming-group-phar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-viridian-therapeutics-vrdn-pharming-group-phar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRDN","BK4137","HCSG","PHAR","BK4139"],"gpt_icon":0},{"id":"2491151694","title":"Viridian Therapeutics Shares up 19.8% After Co's Eye Disorder Drug Meets Late-Stage Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2491151694","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491151694?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:31","pubTimestamp":1734359477,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"2491691931","title":"Viridian Therapeutics Meets Endpoints in Late-Stage Veligrotug Trial for Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2491691931","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491691931?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:10","pubTimestamp":1734358259,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics (VRDN) said Monday that a late-stage trial of candidate drug veligrotug met all of its primary and secondary endpoints for symptoms of chronic thyroid eye disease.Viridian said a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VRDN","BK4139","LENZ","SSI"],"gpt_icon":0},{"id":"2491695825","title":"BUZZ-Viridian jumps as thyroid eye disease drug meets late-stage study goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2491695825","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491695825?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:13","pubTimestamp":1734354825,"startTime":"0","endTime":"0","summary":"** Drug developer Viridian Therapeutics'    shares rise 32.4% to $23.64 premarket ** Company says its drug, veligrotug, helped to significantly relieve symptoms when tested in patients with chronic thyroid eye disease  during a late-stage trial   ** TED causes inflammation and damage to the tissues around the eye and is estimated to affect between 90 and 300 per 100,000 people in the U.S.   ** Company plans to submit a marketing application for U.S. approval in the second half of 2025   ** As of last close, stock down 18% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"2491938196","title":"Viridian Therapeutics announces THRIVE-2 trial met primary, secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2491938196","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491938196?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:40","pubTimestamp":1734352858,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics (VRDN) announced topline data from the THRIVE-2 phase 3 clinical trial of veligrotug, an intravenously delivered anti-insulin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viridian-therapeutics-announces-thrive-2-trial-met-primary-secondary-endpoints?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viridian-therapeutics-announces-thrive-2-trial-met-primary-secondary-endpoints?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRDN","THAC","BK4139","LENZ"],"gpt_icon":0},{"id":"2491661667","title":"Viridian Therapeutics Shares up 14.8% Premarket After Co's Eye Disorder Drug Meets Late-Stage Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2491661667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491661667?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:10","pubTimestamp":1734351014,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4N3NH0UG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRDN","BK4139"],"gpt_icon":0},{"id":"2491466731","title":"Viridian Therapeutics' eye disorder drug meets late-stage study goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2491466731","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491466731?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:08","pubTimestamp":1734350882,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics' eye disorder drug meets late-stage study goalDec 16  - Viridian Therapeutics VRDN.O said on Monday its experimental drug to treat an immune system disorder, chronic thyroid eye disease, met the main goal of a late-stage study.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4N3NH0U5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"2491755662","title":"Viridian Therapeutics Inc: Veligrotug Met All Primary and Secondary Endpoints With High Statistical Significance in Thrive-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2491755662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491755662?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:00","pubTimestamp":1734350402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA1HXCHH:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRDN","BK4139"],"gpt_icon":0},{"id":"2491276662","title":"Viridian Therapeutics Inc - Veligrotug Well-Tolerated With 94% Completion Rate in Thrive-2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2491276662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491276662?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:00","pubTimestamp":1734350402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA1HXCHH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRDN","BK4139"],"gpt_icon":0},{"id":"2491214662","title":"Viridian Therapeutics Announces Positive Topline Results From Veligrotug Phase 3 Thrive-2 Clinical Trial in Patients With Chronic Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2491214662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491214662?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:00","pubTimestamp":1734350402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA1HXCHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"gpt_icon":0},{"id":"2491660734","title":"Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2491660734","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491660734?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:00","pubTimestamp":1734350400,"startTime":"0","endTime":"0","summary":"- Veligrotug met all primary and secondary endpoints with high statistical significance in THRIVE-2, achieving a week 15 proptosis responder rate  of 56%  -. - THRIVE-2 is the first global phase 3 study in patients with chronic TED to demonstrate a statistically significant and clinically meaningful 56% diplopia responder rate  and 32% rate of diplopia complete resolution  -. - Veligrotug was generally well-tolerated with 94% of patients completing their treatment course and a 9.6% placebo-adjusted rate of hearing impairment -. \"We are extremely pleased to announce better-than-expected THRIVE-2 results generated in the broadest population of chronic TED patients studied in a global phase 3 study to date. We believe that these efficacy and safety results in only five infusions, combined with our compelling data from THRIVE, confirm the potential of veli to be the treatment-of-choice for all forms of active and chronic TED,\" said Steve Mahoney, Viridian’s President and CEO. \"The robustne","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oJYBj0e077WL3.gH1kM25Q--~B/aD02MDA7dz0yNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/56204b802211bd79a80bc345712ac81f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oJYBj0e077WL3.gH1kM25Q--~B/aD02MDA7dz0yNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/56204b802211bd79a80bc345712ac81f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viridian-therapeutics-announces-positive-topline-120000827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["THAC","CAS","VRDN","BK4139","LENZ"],"gpt_icon":0},{"id":"2491558701","title":"Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2491558701","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491558701?lang=en_us&edition=fundamental","pubTime":"2024-12-14 07:00","pubTimestamp":1734130800,"startTime":"0","endTime":"0","summary":"- THRIVE-2 global phase 3 clinical trial evaluated efficacy and safety of veligrotug in patients with chronic thyroid eye disease  -. - Conference call and webcast to be held Monday, December 16, at 8:00 a.m. ET -. WALTHAM, Mass., December 13, 2024----Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced plans to host a conference call and webcast to report topline data for the THRIVE-2 phase 3 clinical trial, evaluating veligrotug in chronic TED, on Monday, December 16, 2024 at 8:00am ET.Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease . The company is conducting a pivotal program for veligrotug , including two global phase 3 clinical trials , to evaluate its efficacy and safety in patients with active and chronic TED. Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vRE0xuX_WcyCvRycbBxAoQ--~B/aD02MDA7dz0yNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/11b64a17e8e75ad297ce39c22bd2a669","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vRE0xuX_WcyCvRycbBxAoQ--~B/aD02MDA7dz0yNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/11b64a17e8e75ad297ce39c22bd2a669"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viridian-therapeutics-webcast-veligrotug-phase-230000471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VRDN","LENZ","THAC"],"gpt_icon":0},{"id":"2489618804","title":"Viridian Therapeutics Price Target Maintained With a $44.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2489618804","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489618804?lang=en_us&edition=fundamental","pubTime":"2024-12-06 00:15","pubTimestamp":1733415300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VRDN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2024 11:15 ET (16:15 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VRDN"],"gpt_icon":0},{"id":"2489142720","title":"Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2489142720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489142720?lang=en_us&edition=fundamental","pubTime":"2024-12-05 05:01","pubTimestamp":1733346060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nTUA6MYJPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","BK4139","BK4588","IE00B64PRP62.GBP","VRDN","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2486817430","title":"TD Cowen Initiates Viridian Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2486817430","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486817430?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:34","pubTimestamp":1732541660,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics (VRDN) has an average rating of buy and mean price target of $40.62, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","VRDN","BK4585","BK4207","COWN","TD","BK4139","BK4127","BK4566"],"gpt_icon":0},{"id":"2486088171","title":"Viridian Therapeutics Price Target Maintained With a $38.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2486088171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486088171?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:06","pubTimestamp":1732536360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VRDN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2024 07:06 ET (12:06 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VRDN"],"gpt_icon":0},{"id":"2484328647","title":"Viridian Therapeutics (VRDN) Has Captured Investors’ Attention with Recent Breakthroughs","url":"https://stock-news.laohu8.com/highlight/detail?id=2484328647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484328647?lang=en_us&edition=fundamental","pubTime":"2024-11-18 18:29","pubTimestamp":1731925745,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics ($VRDN) has captured investors’ attention with recent breakthroughs in developing effective treatments for severe and rare di...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/viridian-therapeutics-vrdn-pioneering-breakthroughs-in-thyroid-eye-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/viridian-therapeutics-vrdn-pioneering-breakthroughs-in-thyroid-eye-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ISBC","BK4211","VRDN"],"gpt_icon":0},{"id":"2483822219","title":"Viridian Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2483822219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483822219?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:10","pubTimestamp":1731579007,"startTime":"0","endTime":"0","summary":"NasdaqCM:VRDN Earnings and Revenue History November 14th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 73%. Earnings per share  missed analyst estimates by 7.7%.Looking ahead, revenue is forecast to grow 82% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Biotechs industry in the US.The company's shares are down 7.4% from a week ago.It is worth noting though that we have found 4 warning signs for Viridian Therapeutics (2 are significant!) that you need to take into consideration.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viridian-therapeutics-third-quarter-2024-101007724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","VRDN"],"gpt_icon":0},{"id":"2483194894","title":"Viridian Therapeutics Inc :  H.c. Wainwright Raises Target Price to  $34 From $27","url":"https://stock-news.laohu8.com/highlight/detail?id=2483194894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483194894?lang=en_us&edition=fundamental","pubTime":"2024-11-14 11:54","pubTimestamp":1731556479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3MK30T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VRDN"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRDN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"VRDN","fiscalQuarterEnding":"2025/03","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.87},{"market":"US","date":"2025-02-27","symbol":"VRDN","fiscalQuarterEnding":"2024/12","expectedEps":-1.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2024-11-12","symbol":"VRDN","fiscalQuarterEnding":"2024/09","expectedEps":-1.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-08","symbol":"VRDN","fiscalQuarterEnding":"2024/06","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-1.02},{"market":"US","date":"2024-05-08","symbol":"VRDN","fiscalQuarterEnding":"2024/03","expectedEps":-1.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRDN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRDN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4118,"buy":0.4706,"hold":0.1176,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4706,"analysts":17,"updateTime":1734840000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRDN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRDN","date":"2025-05-09","current":-3.382036,"percent":0.60195,"low":-13.388191,"twenty":-6.526193,"median":-4.001263,"eighty":-1.992998,"high":-0.766505,"avg":-4.464926,"sd":2.805828,"marketCap":1042746092},"quantilePoints":[{"date":"2020-05-15","current":-0.852553,"twenty":-7.263723,"median":-2.829702,"eighty":-0.717905,"marketCap":32642565},{"date":"2020-05-22","current":-0.871129,"twenty":-7.226303,"median":-2.812911,"eighty":-0.72294,"marketCap":33353800},{"date":"2020-05-29","current":-1.368244,"twenty":-7.211666,"median":-2.798727,"eighty":-0.724618,"marketCap":52387334},{"date":"2020-06-05","current":-1.206051,"twenty":-7.20801,"median":-2.776109,"eighty":-0.726254,"marketCap":46177288},{"date":"2020-06-12","current":-1.291029,"twenty":-7.194894,"median":-2.765634,"eighty":-0.731266,"marketCap":49430926},{"date":"2020-06-19","current":-1.760557,"twenty":-7.178123,"median":-2.741996,"eighty":-0.732897,"marketCap":67408225},{"date":"2020-06-26","current":-1.427854,"twenty":-7.178123,"median":-2.713631,"eighty":-0.733032,"marketCap":54669661},{"date":"2020-07-02","current":-1.469442,"twenty":-7.157997,"median":-2.694939,"eighty":-0.736082,"marketCap":56261980},{"date":"2020-07-10","current":-1.300872,"twenty":-7.152966,"median":-2.67581,"eighty":-0.739182,"marketCap":49807778},{"date":"2020-07-17","current":-1.469442,"twenty":-7.139337,"median":-2.66657,"eighty":-0.742524,"marketCap":56261980},{"date":"2020-07-24","current":-1.718969,"twenty":-7.107098,"median":-2.647445,"eighty":-0.743544,"marketCap":65815903},{"date":"2020-07-31","current":-1.538755,"twenty":-7.09989,"median":-2.627292,"eighty":-0.747023,"marketCap":58915848},{"date":"2020-08-07","current":-1.722306,"twenty":-7.096172,"median":-2.609624,"eighty":-0.756086,"marketCap":61705058},{"date":"2020-08-14","current":-1.722306,"twenty":-7.08935,"median":-2.581259,"eighty":-0.759366,"marketCap":61705058},{"date":"2020-08-21","current":-1.690704,"twenty":-7.078266,"median":-2.572456,"eighty":-0.761891,"marketCap":60572856},{"date":"2020-08-28","current":-1.483237,"twenty":-7.075863,"median":-2.5403,"eighty":-0.763281,"marketCap":53139944},{"date":"2020-09-04","current":-1.42272,"twenty":-7.066253,"median":-2.486707,"eighty":-0.771276,"marketCap":50971774},{"date":"2020-09-11","current":-1.435834,"twenty":-7.06385,"median":-2.253314,"eighty":-0.776436,"marketCap":51441637},{"date":"2020-09-18","current":-1.338816,"twenty":-7.06385,"median":-2.210431,"eighty":-0.7835,"marketCap":47965774},{"date":"2020-09-25","current":-1.276877,"twenty":-7.049434,"median":-2.190938,"eighty":-0.787469,"marketCap":45746659},{"date":"2020-10-02","current":-1.169114,"twenty":-7.039823,"median":-2.179242,"eighty":-0.799934,"marketCap":41885847},{"date":"2020-10-09","current":-0.9479,"twenty":-7.032615,"median":-2.144157,"eighty":-0.811143,"marketCap":33960423},{"date":"2020-10-16","current":-0.869053,"twenty":-7.027433,"median":-2.001749,"eighty":-0.81605,"marketCap":31135579},{"date":"2020-10-23","current":-0.774248,"twenty":-7.02215,"median":-1.894655,"eighty":-0.800087,"marketCap":27738970},{"date":"2020-10-30","current":-2.504077,"twenty":-7.00404,"median":-1.902452,"eighty":-0.800087,"marketCap":89713576},{"date":"2020-11-06","current":-1.98797,"twenty":-6.963911,"median":-1.98797,"eighty":-0.811143,"marketCap":71222991},{"date":"2020-11-13","current":-2.394228,"twenty":-6.943717,"median":-2.128563,"eighty":-0.81605,"marketCap":72044726},{"date":"2020-11-20","current":-2.24067,"twenty":-6.943482,"median":-2.167548,"eighty":-0.817924,"marketCap":67424002},{"date":"2020-11-27","current":-2.20038,"twenty":-6.938676,"median":-2.167548,"eighty":-0.819362,"marketCap":66211621},{"date":"2020-12-04","current":-2.174386,"twenty":-6.922093,"median":-2.170967,"eighty":-0.821556,"marketCap":65429440},{"date":"2020-12-11","current":-2.378066,"twenty":-6.906362,"median":-2.175685,"eighty":-0.821651,"marketCap":71558372},{"date":"2020-12-18","current":-2.591066,"twenty":-6.900899,"median":-2.186862,"eighty":-0.823283,"marketCap":77967752},{"date":"2020-12-24","current":-2.289749,"twenty":-6.888455,"median":-2.194837,"eighty":-0.825731,"marketCap":68900825},{"date":"2020-12-31","current":-2.136493,"twenty":-6.859623,"median":-2.190761,"eighty":-0.825732,"marketCap":64289199},{"date":"2021-01-08","current":-2.440407,"twenty":-6.859623,"median":-2.190938,"eighty":-0.825732,"marketCap":73434288},{"date":"2021-01-15","current":-2.99109,"twenty":-6.825925,"median":-2.203456,"eighty":-0.833521,"marketCap":90004878},{"date":"2021-01-22","current":-2.828742,"twenty":-6.819217,"median":-2.215803,"eighty":-0.833962,"marketCap":85119681},{"date":"2021-01-29","current":-2.314425,"twenty":-6.81754,"median":-2.223511,"eighty":-0.837542,"marketCap":69643375},{"date":"2021-02-05","current":-2.688474,"twenty":-6.812764,"median":-2.244569,"eighty":-0.843925,"marketCap":80898870},{"date":"2021-02-12","current":-2.466383,"twenty":-6.802928,"median":-2.289749,"eighty":-0.848329,"marketCap":74215920},{"date":"2021-02-19","current":-2.376767,"twenty":-6.800041,"median":-2.292658,"eighty":-0.849095,"marketCap":71519291},{"date":"2021-02-26","current":-2.135194,"twenty":-6.78514,"median":-2.293234,"eighty":-0.851172,"marketCap":64250117},{"date":"2021-03-05","current":-2.084541,"twenty":-6.768322,"median":-2.270267,"eighty":-0.853608,"marketCap":62725935},{"date":"2021-03-12","current":-2.337803,"twenty":-6.756308,"median":-2.287151,"eighty":-0.855859,"marketCap":70346844},{"date":"2021-03-19","current":-2.335206,"twenty":-6.745843,"median":-2.293811,"eighty":-0.856891,"marketCap":70268680},{"date":"2021-03-26","current":-1.181434,"twenty":-6.726105,"median":-2.293234,"eighty":-0.863275,"marketCap":130802476},{"date":"2021-04-01","current":-1.029918,"twenty":-6.710658,"median":-2.287151,"eighty":-0.867695,"marketCap":114027366},{"date":"2021-04-09","current":-1.022734,"twenty":-6.70345,"median":-2.270267,"eighty":-0.868386,"marketCap":113231994},{"date":"2021-04-16","current":-0.963956,"twenty":-6.698772,"median":-2.244569,"eighty":-0.869883,"marketCap":106724408},{"date":"2021-04-23","current":-1.204945,"twenty":-6.679087,"median":-2.223511,"eighty":-0.871666,"marketCap":133405510},{"date":"2021-04-30","current":-1.192002,"twenty":-6.652627,"median":-2.215803,"eighty":-0.874208,"marketCap":131972502},{"date":"2021-05-07","current":-1.219933,"twenty":-6.622996,"median":-2.206532,"eighty":-0.878192,"marketCap":147771659},{"date":"2021-05-14","current":-1.212278,"twenty":-6.588724,"median":-2.199558,"eighty":-0.881403,"marketCap":146844398},{"date":"2021-05-21","current":-1.235243,"twenty":-6.543489,"median":-2.190583,"eighty":-0.883427,"marketCap":149626181},{"date":"2021-05-28","current":-1.253336,"twenty":-6.489183,"median":-2.180535,"eighty":-0.883983,"marketCap":151817888},{"date":"2021-06-04","current":-1.116938,"twenty":-6.487209,"median":-2.175515,"eighty":-0.884116,"marketCap":135295786},{"date":"2021-06-11","current":-1.13016,"twenty":-6.478042,"median":-2.174157,"eighty":-0.884232,"marketCap":136897418},{"date":"2021-06-18","current":-1.178178,"twenty":-6.435271,"median":-2.167606,"eighty":-0.885199,"marketCap":142713872},{"date":"2021-06-25","current":-1.270038,"twenty":-6.410779,"median":-2.160006,"eighty":-0.887378,"marketCap":153841003},{"date":"2021-07-02","current":-1.230371,"twenty":-6.404151,"median":-2.144389,"eighty":-0.889609,"marketCap":149036105},{"date":"2021-07-09","current":-1.238026,"twenty":-6.379089,"median":-2.140325,"eighty":-0.895841,"marketCap":149963366},{"date":"2021-07-16","current":-1.25612,"twenty":-6.355062,"median":-2.124804,"eighty":-0.895841,"marketCap":152155074},{"date":"2021-07-23","current":-1.196968,"twenty":-6.319022,"median":-2.095671,"eighty":-0.895841,"marketCap":144989876},{"date":"2021-07-30","current":-1.080402,"twenty":-6.289243,"median":-2.035,"eighty":-0.899122,"marketCap":130870223},{"date":"2021-08-06","current":-1.006984,"twenty":-6.282982,"median":-1.978233,"eighty":-0.901073,"marketCap":121976948},{"date":"2021-08-13","current":-0.846963,"twenty":-6.270969,"median":-1.894655,"eighty":-0.895841,"marketCap":112358074},{"date":"2021-08-20","current":-0.976794,"twenty":-6.246942,"median":-1.879061,"eighty":-0.895841,"marketCap":129581541},{"date":"2021-08-27","current":-0.989742,"twenty":-6.23079,"median":-1.847873,"eighty":-0.895841,"marketCap":131299117},{"date":"2021-09-03","current":-0.878971,"twenty":-6.220019,"median":-1.843975,"eighty":-0.895841,"marketCap":116604303},{"date":"2021-09-10","current":-0.881848,"twenty":-6.211165,"median":-1.832913,"eighty":-0.887883,"marketCap":116985986},{"date":"2021-09-17","current":-0.836533,"twenty":-6.191243,"median":-1.824482,"eighty":-0.884116,"marketCap":110974471},{"date":"2021-09-24","current":-2.082596,"twenty":-6.169107,"median":-1.824482,"eighty":-0.884116,"marketCap":276277160},{"date":"2021-10-01","current":-2.155669,"twenty":-6.16468,"median":-1.832913,"eighty":-0.88458,"marketCap":285971095},{"date":"2021-10-08","current":-2.113913,"twenty":-6.111556,"median":-1.843975,"eighty":-0.886707,"marketCap":280431703},{"date":"2021-10-15","current":-2.227438,"twenty":-6.089421,"median":-1.847873,"eighty":-0.887883,"marketCap":295491924},{"date":"2021-10-22","current":-2.111303,"twenty":-6.087207,"median":-1.870598,"eighty":-0.892871,"marketCap":280085491},{"date":"2021-10-29","current":-2.361841,"twenty":-6.069499,"median":-1.894655,"eighty":-0.895488,"marketCap":313321841},{"date":"2021-11-05","current":-2.921254,"twenty":-6.018588,"median":-1.939373,"eighty":-0.895841,"marketCap":412507407},{"date":"2021-11-12","current":-2.952021,"twenty":-5.982617,"median":-2.013109,"eighty":-0.895841,"marketCap":416851877},{"date":"2021-11-19","current":-2.992017,"twenty":-5.958822,"median":-2.045809,"eighty":-0.898466,"marketCap":422499688},{"date":"2021-11-26","current":-2.815111,"twenty":-5.920891,"median":-2.083569,"eighty":-0.900293,"marketCap":397518986},{"date":"2021-12-03","current":-2.89818,"twenty":-5.804851,"median":-2.095645,"eighty":-0.902608,"marketCap":409249055},{"date":"2021-12-10","current":-3.153539,"twenty":-5.720757,"median":-2.112136,"eighty":-0.903933,"marketCap":445308154},{"date":"2021-12-17","current":-3.162769,"twenty":-5.684717,"median":-2.124804,"eighty":-0.904228,"marketCap":446611495},{"date":"2021-12-23","current":-3.307371,"twenty":-5.627053,"median":-2.136493,"eighty":-0.905383,"marketCap":467030503},{"date":"2021-12-31","current":-3.041243,"twenty":-5.557376,"median":-2.144389,"eighty":-0.907202,"marketCap":429450839},{"date":"2022-01-07","current":-3.076624,"twenty":-5.545363,"median":-2.155669,"eighty":-0.907579,"marketCap":434446980},{"date":"2022-01-14","current":-3.076624,"twenty":-5.504517,"median":-2.159795,"eighty":-0.909214,"marketCap":434446980},{"date":"2022-01-21","current":-2.690508,"twenty":-5.44445,"median":-2.163499,"eighty":-0.911625,"marketCap":379923884},{"date":"2022-01-28","current":-2.819726,"twenty":-5.386787,"median":-2.167548,"eighty":-0.912939,"marketCap":398170657},{"date":"2022-02-04","current":-3.041243,"twenty":-5.30029,"median":-2.168191,"eighty":-0.914935,"marketCap":429450839},{"date":"2022-02-11","current":-3.102775,"twenty":-5.259444,"median":-2.174386,"eighty":-0.915713,"marketCap":438139779},{"date":"2022-02-18","current":-2.707429,"twenty":-5.237821,"median":-2.176769,"eighty":-0.919624,"marketCap":382313342},{"date":"2022-02-25","current":-2.876643,"twenty":-5.189767,"median":-2.180535,"eighty":-0.922817,"marketCap":406207926},{"date":"2022-03-04","current":-2.616669,"twenty":-5.165741,"median":-2.184377,"eighty":-0.923707,"marketCap":369497156},{"date":"2022-03-11","current":-6.552298,"twenty":-5.189767,"median":-2.194837,"eighty":-0.924357,"marketCap":520337638},{"date":"2022-03-18","current":-6.526193,"twenty":-5.406008,"median":-2.205328,"eighty":-0.928044,"marketCap":518264580},{"date":"2022-03-25","current":-6.61756,"twenty":-5.562181,"median":-2.211127,"eighty":-0.932198,"marketCap":525520284},{"date":"2022-04-01","current":-6.095464,"twenty":-5.742381,"median":-2.218304,"eighty":-0.932257,"marketCap":484059117},{"date":"2022-04-08","current":-6.06936,"twenty":-5.964941,"median":-2.225474,"eighty":-0.936527,"marketCap":481986059},{"date":"2022-04-14","current":-6.190094,"twenty":-5.982617,"median":-2.237286,"eighty":-0.942797,"marketCap":491573954},{"date":"2022-04-22","current":-5.034958,"twenty":-5.967259,"median":-2.253314,"eighty":-0.944918,"marketCap":399841123},{"date":"2022-04-29","current":-4.707683,"twenty":-5.956504,"median":-2.270917,"eighty":-0.946466,"marketCap":373851246},{"date":"2022-05-06","current":-3.482864,"twenty":-5.909723,"median":-2.282243,"eighty":-0.947207,"marketCap":276584715},{"date":"2022-05-13","current":-4.357717,"twenty":-5.873349,"median":-2.284051,"eighty":-0.947781,"marketCap":377578758},{"date":"2022-05-20","current":-4.377056,"twenty":-5.833111,"median":-2.286158,"eighty":-0.949254,"marketCap":379254404},{"date":"2022-05-27","current":-3.929036,"twenty":-5.806354,"median":-2.291203,"eighty":-0.953515,"marketCap":340435286},{"date":"2022-06-03","current":-3.845234,"twenty":-5.766143,"median":-2.300851,"eighty":-0.95564,"marketCap":333174156},{"date":"2022-06-10","current":-3.503579,"twenty":-5.738553,"median":-2.314425,"eighty":-0.957457,"marketCap":303571088},{"date":"2022-06-17","current":-3.487463,"twenty":-5.718205,"median":-2.322868,"eighty":-0.95816,"marketCap":302174716},{"date":"2022-06-24","current":-3.53581,"twenty":-5.691925,"median":-2.327738,"eighty":-0.95986,"marketCap":306363830},{"date":"2022-07-01","current":-3.448785,"twenty":-5.644581,"median":-2.335206,"eighty":-0.962697,"marketCap":298823426},{"date":"2022-07-08","current":-3.967714,"twenty":-5.597236,"median":-2.337048,"eighty":-0.963294,"marketCap":343786577},{"date":"2022-07-15","current":-4.341601,"twenty":-5.559778,"median":-2.338078,"eighty":-0.964002,"marketCap":376182387},{"date":"2022-07-22","current":-4.180443,"twenty":-5.547765,"median":-2.361841,"eighty":-0.964772,"marketCap":362218676},{"date":"2022-07-29","current":-4.267469,"twenty":-5.536061,"median":-2.36967,"eighty":-0.968337,"marketCap":369759080},{"date":"2022-08-05","current":-4.399618,"twenty":-5.512961,"median":-2.376767,"eighty":-0.973414,"marketCap":381209323},{"date":"2022-08-12","current":-4.74772,"twenty":-5.44445,"median":-2.38391,"eighty":-0.97478,"marketCap":411370940},{"date":"2022-08-19","current":-9.166514,"twenty":-5.559778,"median":-2.389755,"eighty":-0.977513,"marketCap":899904148},{"date":"2022-08-26","current":-9.353109,"twenty":-5.730069,"median":-2.39394,"eighty":-0.980761,"marketCap":918222808},{"date":"2022-09-02","current":-8.540641,"twenty":-5.858564,"median":-2.408502,"eighty":-0.982448,"marketCap":838460311},{"date":"2022-09-09","current":-9.213243,"twenty":-5.964941,"median":-2.417029,"eighty":-0.983268,"marketCap":904491717},{"date":"2022-09-16","current":-8.940951,"twenty":-6.065072,"median":-2.431316,"eighty":-0.988194,"marketCap":877759938},{"date":"2022-09-23","current":-8.408558,"twenty":-6.095464,"median":-2.440407,"eighty":-0.989742,"marketCap":825493323},{"date":"2022-09-30","current":-8.335404,"twenty":-6.16468,"median":-2.461901,"eighty":-0.999812,"marketCap":818311651},{"date":"2022-10-07","current":-8.193162,"twenty":-6.190094,"median":-2.470279,"eighty":-1.003794,"marketCap":804347288},{"date":"2022-10-14","current":-8.522351,"twenty":-6.23079,"median":-2.490182,"eighty":-1.003794,"marketCap":836664813},{"date":"2022-10-21","current":-8.132201,"twenty":-6.282982,"median":-2.504077,"eighty":-1.004901,"marketCap":798362561},{"date":"2022-10-28","current":-8.140329,"twenty":-6.355062,"median":-2.525477,"eighty":-1.005592,"marketCap":799160525},{"date":"2022-11-04","current":-7.994023,"twenty":-6.410869,"median":-2.544309,"eighty":-1.006984,"marketCap":784797180},{"date":"2022-11-11","current":-8.335404,"twenty":-6.490499,"median":-2.57213,"eighty":-1.011563,"marketCap":818311651},{"date":"2022-11-18","current":-8.029354,"twenty":-6.526193,"median":-2.579376,"eighty":-1.01269,"marketCap":907597992},{"date":"2022-11-25","current":-8.121932,"twenty":-6.557602,"median":-2.581259,"eighty":-1.016023,"marketCap":918062536},{"date":"2022-12-02","current":-9.791895,"twenty":-6.597216,"median":-2.583049,"eighty":-1.017309,"marketCap":1106826820},{"date":"2022-12-09","current":-9.631664,"twenty":-6.662022,"median":-2.606651,"eighty":-1.020119,"marketCap":1088715108},{"date":"2022-12-16","current":-9.927201,"twenty":-6.705853,"median":-2.612477,"eighty":-1.022346,"marketCap":1122121154},{"date":"2022-12-23","current":-10.532518,"twenty":-6.753906,"median":-2.618207,"eighty":-1.026392,"marketCap":1190543175},{"date":"2022-12-30","current":-10.400773,"twenty":-6.800041,"median":-2.626049,"eighty":-1.028873,"marketCap":1175651324},{"date":"2023-01-06","current":-9.777652,"twenty":-6.800041,"median":-2.626049,"eighty":-1.028873,"marketCap":1105216890},{"date":"2023-01-13","current":-12.900376,"twenty":-6.800041,"median":-2.626049,"eighty":-1.028873,"marketCap":1458194025},{"date":"2023-01-20","current":-12.804238,"twenty":-6.813958,"median":-2.626049,"eighty":-1.028873,"marketCap":1447326998},{"date":"2023-01-27","current":-12.935983,"twenty":-6.839404,"median":-2.626049,"eighty":-1.028873,"marketCap":1462218849},{"date":"2023-02-03","current":-13.345462,"twenty":-6.905704,"median":-2.626049,"eighty":-1.028873,"marketCap":1508504335},{"date":"2023-02-10","current":-11.828609,"twenty":-6.963911,"median":-2.626049,"eighty":-1.028873,"marketCap":1337046798},{"date":"2023-02-17","current":-11.739592,"twenty":-7.06385,"median":-2.626049,"eighty":-1.028873,"marketCap":1326984736},{"date":"2023-02-24","current":-11.714667,"twenty":-7.080669,"median":-2.626049,"eighty":-1.028873,"marketCap":1324167359},{"date":"2023-03-03","current":-11.736031,"twenty":-7.164762,"median":-2.626049,"eighty":-1.028873,"marketCap":1326582254},{"date":"2023-03-10","current":-9.383947,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1218730787},{"date":"2023-03-17","current":-9.066855,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1177548754},{"date":"2023-03-24","current":-8.502035,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1104193258},{"date":"2023-03-31","current":-8.402943,"twenty":-7.28009,"median":-2.627292,"eighty":-1.029396,"marketCap":1091323873},{"date":"2023-04-06","current":-8.231185,"twenty":-7.28009,"median":-2.627292,"eighty":-1.029396,"marketCap":1069016938},{"date":"2023-04-14","current":-8.667187,"twenty":-7.275334,"median":-2.626049,"eighty":-1.028873,"marketCap":1125642234},{"date":"2023-04-21","current":-9.492948,"twenty":-7.28009,"median":-2.626049,"eighty":-1.028873,"marketCap":1232887111},{"date":"2023-04-28","current":-9.165947,"twenty":-7.28009,"median":-2.626049,"eighty":-1.028873,"marketCap":1190418140},{"date":"2023-05-05","current":-9.11144,"twenty":-7.28009,"median":-2.626049,"eighty":-1.028873,"marketCap":1183339222},{"date":"2023-05-12","current":-5.966384,"twenty":-7.218934,"median":-2.626049,"eighty":-1.028873,"marketCap":1028198864},{"date":"2023-05-19","current":-5.648973,"twenty":-7.080669,"median":-2.626049,"eighty":-1.028873,"marketCap":973498899},{"date":"2023-05-26","current":-5.959329,"twenty":-7.049434,"median":-2.626049,"eighty":-1.028873,"marketCap":1026983110},{"date":"2023-06-02","current":-6.132027,"twenty":-6.943717,"median":-2.626049,"eighty":-1.028873,"marketCap":1056744486},{"date":"2023-06-09","current":-6.374805,"twenty":-6.859623,"median":-2.626049,"eighty":-1.028873,"marketCap":1098582941},{"date":"2023-06-16","current":-6.975494,"twenty":-6.78514,"median":-2.626049,"eighty":-1.028873,"marketCap":1202100768},{"date":"2023-06-23","current":-6.672647,"twenty":-6.747315,"median":-2.623667,"eighty":-1.028351,"marketCap":1149910530},{"date":"2023-06-30","current":-5.991866,"twenty":-6.672071,"median":-2.621284,"eighty":-1.027828,"marketCap":1032590326},{"date":"2023-07-07","current":-5.826677,"twenty":-6.602877,"median":-2.621284,"eighty":-1.027828,"marketCap":1004122923},{"date":"2023-07-14","current":-5.361144,"twenty":-6.531414,"median":-2.621284,"eighty":-1.027828,"marketCap":923896607},{"date":"2023-07-21","current":-5.13088,"twenty":-6.494902,"median":-2.621284,"eighty":-1.027828,"marketCap":884214774},{"date":"2023-07-28","current":-4.628551,"twenty":-6.381669,"median":-2.621284,"eighty":-1.027828,"marketCap":797647500},{"date":"2023-08-04","current":-4.608184,"twenty":-6.342478,"median":-2.621284,"eighty":-1.027828,"marketCap":794137500},{"date":"2023-08-11","current":-4.307348,"twenty":-6.269528,"median":-2.621284,"eighty":-1.027828,"marketCap":852441464},{"date":"2023-08-18","current":-4.20143,"twenty":-6.226635,"median":-2.621284,"eighty":-1.027828,"marketCap":831479789},{"date":"2023-08-25","current":-4.148471,"twenty":-6.182084,"median":-2.621284,"eighty":-1.027828,"marketCap":820998951},{"date":"2023-09-01","current":-4.009453,"twenty":-6.136032,"median":-2.621284,"eighty":-1.027828,"marketCap":793486752},{"date":"2023-09-08","current":-4.133024,"twenty":-6.08145,"median":-2.621284,"eighty":-1.027828,"marketCap":817942040},{"date":"2023-09-15","current":-3.866022,"twenty":-5.991866,"median":-2.621284,"eighty":-1.027828,"marketCap":765101150},{"date":"2023-09-22","current":-3.473241,"twenty":-5.955324,"median":-2.621284,"eighty":-1.027828,"marketCap":687368271},{"date":"2023-09-29","current":-3.345256,"twenty":-5.863774,"median":-2.621284,"eighty":-1.027828,"marketCap":662039580},{"date":"2023-10-06","current":-3.208445,"twenty":-5.824627,"median":-2.619746,"eighty":-1.027306,"marketCap":634964082},{"date":"2023-10-13","current":-2.68106,"twenty":-5.779123,"median":-2.619746,"eighty":-1.027306,"marketCap":530592407},{"date":"2023-10-20","current":-2.595001,"twenty":-5.734071,"median":-2.616,"eighty":-1.027306,"marketCap":513561046},{"date":"2023-10-27","current":-2.795804,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":553300889},{"date":"2023-11-03","current":-3.10694,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":614875810},{"date":"2023-11-10","current":-3.602354,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":712920242},{"date":"2023-11-17","current":-3.689243,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":799307792},{"date":"2023-11-24","current":-3.958655,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":857678296},{"date":"2023-12-01","current":-4.063022,"twenty":-5.735229,"median":-2.609624,"eighty":-1.024563,"marketCap":880290292},{"date":"2023-12-08","current":-4.512042,"twenty":-5.734843,"median":-2.610036,"eighty":-1.025477,"marketCap":977574465},{"date":"2023-12-15","current":-4.694077,"twenty":-5.734843,"median":-2.610036,"eighty":-1.025477,"marketCap":1017013994},{"date":"2023-12-22","current":-5.186785,"twenty":-5.734843,"median":-2.612889,"eighty":-1.025477,"marketCap":1123763653},{"date":"2023-12-29","current":-5.434353,"twenty":-5.735229,"median":-2.616669,"eighty":-1.024563,"marketCap":1177401413},{"date":"2024-01-05","current":-5.339694,"twenty":-5.735615,"median":-2.613558,"eighty":-1.023648,"marketCap":1156892858},{"date":"2024-01-12","current":-5.536292,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1199487549},{"date":"2024-01-19","current":-4.888248,"twenty":-5.752307,"median":-2.610447,"eighty":-1.022734,"marketCap":1059082825},{"date":"2024-01-26","current":-5.425414,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1175464692},{"date":"2024-02-02","current":-5.513632,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1194577940},{"date":"2024-02-09","current":-4.951241,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1072730990},{"date":"2024-02-16","current":-5.301357,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1148586689},{"date":"2024-02-23","current":-4.959512,"twenty":-5.749661,"median":-2.613558,"eighty":-1.023648,"marketCap":1074522857},{"date":"2024-03-01","current":-4.939896,"twenty":-5.747015,"median":-2.616669,"eighty":-1.024563,"marketCap":1174381234},{"date":"2024-03-08","current":-5.111512,"twenty":-5.747015,"median":-2.621284,"eighty":-1.024563,"marketCap":1215180155},{"date":"2024-03-15","current":-4.55442,"twenty":-5.747015,"median":-2.63799,"eighty":-1.024563,"marketCap":1082740582},{"date":"2024-03-22","current":-4.958378,"twenty":-5.747015,"median":-2.63799,"eighty":-1.024563,"marketCap":1178774964},{"date":"2024-03-28","current":-4.623067,"twenty":-5.747015,"median":-2.63799,"eighty":-1.024563,"marketCap":1099060150},{"date":"2024-04-05","current":-4.308878,"twenty":-5.749661,"median":-2.638754,"eighty":-1.023648,"marketCap":1024366742},{"date":"2024-04-12","current":-4.279835,"twenty":-5.749661,"median":-2.638754,"eighty":-1.023648,"marketCap":1017462309},{"date":"2024-04-19","current":-4.002609,"twenty":-5.749661,"median":-2.655735,"eighty":-1.023648,"marketCap":951556361},{"date":"2024-04-26","current":-3.35311,"twenty":-5.747015,"median":-2.666786,"eighty":-1.024563,"marketCap":797148139},{"date":"2024-05-03","current":-3.914171,"twenty":-5.747015,"median":-2.67051,"eighty":-1.024563,"marketCap":930531583},{"date":"2024-05-10","current":-4.070008,"twenty":-5.747015,"median":-2.677955,"eighty":-1.024563,"marketCap":887770529},{"date":"2024-05-17","current":-4.280677,"twenty":-5.747015,"median":-2.707429,"eighty":-1.024563,"marketCap":933722706},{"date":"2024-05-24","current":-3.557965,"twenty":-5.747015,"median":-2.758292,"eighty":-1.024563,"marketCap":776081210},{"date":"2024-05-31","current":-3.493594,"twenty":-5.747015,"median":-2.77973,"eighty":-1.024563,"marketCap":762040267},{"date":"2024-06-07","current":-3.578447,"twenty":-5.747015,"median":-2.815111,"eighty":-1.024563,"marketCap":780548783},{"date":"2024-06-14","current":-3.847635,"twenty":-5.749661,"median":-2.834523,"eighty":-1.023648,"marketCap":839265454},{"date":"2024-06-21","current":-3.622337,"twenty":-5.752307,"median":-2.848224,"eighty":-1.022734,"marketCap":790122153},{"date":"2024-06-28","current":-3.739375,"twenty":-5.768397,"median":-2.880489,"eighty":-1.021569,"marketCap":815651141},{"date":"2024-07-05","current":-3.584299,"twenty":-5.768397,"median":-2.895281,"eighty":-1.021569,"marketCap":781825233},{"date":"2024-07-12","current":-3.789116,"twenty":-5.768397,"median":-2.923562,"eighty":-1.021569,"marketCap":826500960},{"date":"2024-07-15","current":-4.064156,"twenty":-5.768397,"median":-2.928473,"eighty":-1.021569,"marketCap":886494080},{"date":"2024-08-02","current":-4.76346,"twenty":-5.806354,"median":-2.976634,"eighty":-1.016023,"marketCap":1039029779},{"date":"2024-08-09","current":-4.235889,"twenty":-5.806354,"median":-2.999708,"eighty":-1.017309,"marketCap":966015590},{"date":"2024-08-16","current":-4.179858,"twenty":-5.806354,"median":-3.018168,"eighty":-1.041063,"marketCap":953237606},{"date":"2024-08-23","current":-4.297522,"twenty":-5.806354,"median":-3.024321,"eighty":-1.080768,"marketCap":980071372},{"date":"2024-08-30","current":-4.202271,"twenty":-5.806354,"median":-3.053981,"eighty":-1.091308,"marketCap":958348800},{"date":"2024-09-06","current":-3.773639,"twenty":-5.806354,"median":-3.075086,"eighty":-1.113319,"marketCap":860597222},{"date":"2024-09-13","current":-5.799133,"twenty":-5.806354,"median":-3.0797,"eighty":-1.130096,"marketCap":1322521344},{"date":"2024-09-20","current":-7.533366,"twenty":-5.863774,"median":-3.10739,"eighty":-1.155212,"marketCap":1718021700},{"date":"2024-09-27","current":-7.719827,"twenty":-5.96033,"median":-3.127388,"eighty":-1.161894,"marketCap":1760545101},{"date":"2024-10-04","current":-7.994339,"twenty":-5.993368,"median":-3.159693,"eighty":-1.172472,"marketCap":1823149047},{"date":"2024-10-11","current":-7.364969,"twenty":-6.086671,"median":-3.175076,"eighty":-1.179321,"marketCap":1679618050},{"date":"2024-10-18","current":-8.121552,"twenty":-6.144411,"median":-3.213534,"eighty":-1.191464,"marketCap":1852160631},{"date":"2024-10-25","current":-7.820258,"twenty":-6.191496,"median":-3.307371,"eighty":-1.196968,"marketCap":1783448984},{"date":"2024-10-31","current":-7.42188,"twenty":-6.228864,"median":-3.355313,"eighty":-1.200789,"marketCap":1692596916},{"date":"2024-11-08","current":-8.272199,"twenty":-6.334811,"median":-3.392854,"eighty":-1.206301,"marketCap":1886516455},{"date":"2024-11-15","current":-6.667719,"twenty":-6.407343,"median":-3.426563,"eighty":-1.212218,"marketCap":1714163845},{"date":"2024-11-22","current":-6.045316,"twenty":-6.407343,"median":-3.453285,"eighty":-1.219655,"marketCap":1554154096},{"date":"2024-11-29","current":-6.639988,"twenty":-6.507267,"median":-3.490528,"eighty":-1.224951,"marketCap":1707034697},{"date":"2024-12-06","current":-6.048398,"twenty":-6.524235,"median":-3.515423,"eighty":-1.230585,"marketCap":1554946223},{"date":"2024-12-13","current":-5.543081,"twenty":-6.524235,"median":-3.558169,"eighty":-1.241784,"marketCap":1425037318},{"date":"2024-12-20","current":-5.771089,"twenty":-6.526193,"median":-3.568206,"eighty":-1.25264,"marketCap":1483654751},{"date":"2024-12-27","current":-6.110022,"twenty":-6.526193,"median":-3.582617,"eighty":-1.259182,"marketCap":1570788773},{"date":"2025-01-03","current":-6.088453,"twenty":-6.526193,"median":-3.602105,"eighty":-1.268646,"marketCap":1565243880},{"date":"2025-01-10","current":-5.9005,"twenty":-6.526193,"median":-3.612259,"eighty":-1.276888,"marketCap":1516924105},{"date":"2025-01-17","current":-5.256529,"twenty":-6.526193,"median":-3.647416,"eighty":-1.292889,"marketCap":1351369463},{"date":"2025-01-24","current":-5.780333,"twenty":-6.526193,"median":-3.689243,"eighty":-1.301593,"marketCap":1486031133},{"date":"2025-01-31","current":-6.187052,"twenty":-6.526193,"median":-3.707456,"eighty":-1.331747,"marketCap":1590591959},{"date":"2025-02-07","current":-5.703303,"twenty":-6.526193,"median":-3.754986,"eighty":-1.3811,"marketCap":1466227946},{"date":"2025-02-14","current":-5.244204,"twenty":-6.526193,"median":-3.774325,"eighty":-1.422341,"marketCap":1348200953},{"date":"2025-02-21","current":-5.120956,"twenty":-6.526193,"median":-3.806672,"eighty":-1.431046,"marketCap":1316515855},{"date":"2025-02-28","current":-4.486636,"twenty":-6.526193,"median":-3.847635,"eighty":-1.45435,"marketCap":1211162901},{"date":"2025-03-07","current":-4.793428,"twenty":-6.526193,"median":-3.865607,"eighty":-1.469442,"marketCap":1293981006},{"date":"2025-03-14","current":-4.772298,"twenty":-6.526193,"median":-3.913546,"eighty":-1.491451,"marketCap":1288277059},{"date":"2025-03-21","current":-4.62439,"twenty":-6.526193,"median":-3.933837,"eighty":-1.538755,"marketCap":1248349434},{"date":"2025-03-28","current":-4.428185,"twenty":-6.526193,"median":-3.958655,"eighty":-1.554954,"marketCap":1195384216},{"date":"2025-04-04","current":-3.818442,"twenty":-6.526193,"median":-3.961657,"eighty":-1.608794,"marketCap":1030784617},{"date":"2025-04-11","current":-3.444144,"twenty":-6.526193,"median":-3.958822,"eighty":-1.69092,"marketCap":929743279},{"date":"2025-04-17","current":-3.818442,"twenty":-6.526193,"median":-3.964491,"eighty":-1.722306,"marketCap":1030784617},{"date":"2025-04-25","current":-4.093128,"twenty":-6.526193,"median":-3.973947,"eighty":-1.772869,"marketCap":1104935922},{"date":"2025-05-02","current":-4.147462,"twenty":-6.526193,"median":-3.992023,"eighty":-1.832913,"marketCap":1119603213},{"date":"2025-05-09","current":-3.382036,"twenty":-6.526193,"median":-4.001263,"eighty":-1.992998,"marketCap":1042746092}],"updateTime":1747122750441}}}